EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Serum thymidine kinase 1 protein concentrations and presence of its autoantibody as biomarkers for screening dogs with malignant tumors

Yoonhee Kim iD, Jeongjoo Park, Byunggak Kim, Kyung-Rok Yu, Hong Sook Kim, Yein Oh, Kyoungwon Seo, Minok Ryu, Chul Park, Dongha Bhang, Ulsoo Choi iD, Hwayoung Youn

Journal of Veterinary Internal Medicine · 2024

DOI: 10.1111/jvim.16946 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Veterinary Internal Medicine, 2024. Verfasst von Yoonhee Kim und 11 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, Jeonbuk National University, 79 Gobong-ro, Iksan-si, Jeollabuk-do, South Korea. Hauptthemen laut MEDLINE: Neoplasms, Dog Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Biattic Incorporated, Anyang, Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

An accurate and easily accessible method for diagnosing malignancies in local veterinary clinics has not yet been established.

Objectives

To investigate the usefulness of serum thymidine kinase 1 (TK1) protein and its autoantibody as tumor biomarkers in dogs. Animals Serum samples from 1702 dogs were collected from local animal hospitals and referral animal medical centers in South Korea.

Methods

TK1 protein OD value and TK1 autoantibody ratio (TK1 autoantibody OD/total IgG OD) in serum samples of dogs classified into healthy controls, group with nontumor disease, group with benign and group with malignant tumors were measured using lateral flow immunochromatographic assay methods.

Results

TK1 autoantibody levels were significantly higher in malignant tumor group (median 0.71) than in healthy controls (median 0.34), group with nontumor disease (median 0.34), and group with benign tumor (median 0.32, Welch t test, P < .0001). They were also significantly different among dogs with carcinomas (median 0.77), hematopoietic tumors (median 0.71), and sarcomas (median 0.56) than in healthy controls (median 0.34, post hoc Games-Howell test, P < .0001). In the receiver operating characteristic curve of TK1 protein, AUC was 0.633 (95% CI: 0.592-0.675, P < .0001). The AUC of TK1 autoantibody ratio was 0.758 (95% CI: 0.723-0.793, P < .0001). Conclusions and Clinical Importance TK1 autoantibody is a potentially useful biomarker for differentiating between healthy and tumor-bearing dogs, better than TK1 protein measurement. However, both were inadequate when used as single biomarkers for screening dogs to discover occult malignant tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsDog DiseasesDogsAnimalsAutoantibodiesBiomarkers, TumorThymidine Kinase

Stichwörter der Autor:innen

autoantibodybiomarkermalignant tumorsthymidine kinase 1 protein

Substanzen

thymidine kinase 1AutoantibodiesBiomarkers, TumorThymidine Kinase

Autor:innen und Institutionen

  • College of Veterinary Medicine, Jeonbuk National University, 79 Gobong-ro, Iksan-si, Jeollabuk-do, South Korea.
  • Biattic Inc., #305, 16 Heungan-daero, Dongan-gu, Anyang-si, Gyeonggi-do, South Korea.
  • Department of Agricultural Biotechnology and Research Institute of Agriculture and Life Sciences, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul, South Korea.
  • Department of Biological Sciences, Sungkyunkwan University, 2066 Seobu-ro, Jangan-gu, Suwon, Gyeonggi-do, South Korea.
  • College of Veterinary Medicine, Kyungpook National University, 80 Daehak-ro, Buk-gu, Daegu, South Korea.
  • College of Veterinary Medicine, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul, South Korea.

ORCID-Profile: Yoonhee Kim, Ulsoo Choi

Förderung

  • Biattic Incorporated, Anyang, Korea

Zitieren

APA

Kim, Y., Park, J., Kim, B., Yu, K. R., Kim, H. S., Oh, Y., Seo, K., Ryu, M., Park, C., Bhang, D., Choi, U., & Youn, H. (2024). Serum thymidine kinase 1 protein concentrations and presence of its autoantibody as biomarkers for screening dogs with malignant tumors. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.16946

Vancouver

Kim Y, Park J, Kim B, Yu KR, Kim HS, Oh Y, et al. Serum thymidine kinase 1 protein concentrations and presence of its autoantibody as biomarkers for screening dogs with malignant tumors. Journal of Veterinary Internal Medicine. 2024. doi:10.1111/jvim.16946

BibTeX
@article{Kim2024,
  author = {Kim, Yoonhee and Park, Jeongjoo and Kim, Byunggak and Yu, Kyung-Rok and Kim, Hong Sook and Oh, Yein and Seo, Kyoungwon and Ryu, Minok and Park, Chul and Bhang, Dongha and Choi, Ulsoo and Youn, Hwayoung},
  title = {Serum thymidine kinase 1 protein concentrations and presence of its autoantibody as biomarkers for screening dogs with malignant tumors},
  journal = {Journal of Veterinary Internal Medicine},
  year = {2024},
  doi = {10.1111/jvim.16946}
}
Kostenlos starten →